title: Ozanimod: a better or just another S1P receptor modulator?
authors.affiliation: Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital Rigshospitalet, Copenhagen DK-2100, Denmark. Electronic address: pss@rh.dk.
authors.forename: Per Soelberg
authors.initials: PS
authors.lastname: Sørensen
mesh_terms: D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology*; D007189:Indans / Q000494:pharmacology*; D008297:Male; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D017063:Outcome Assessment, Health Care; D010069:Oxadiazoles / Q000494:pharmacology*; D049349:Receptors, Lysosphingolipid / Q000187:drug effects*
chemical_list: D007155:Immunologic Factors; D007189:Indans; D010069:Oxadiazoles; D049349:Receptors, Lysosphingolipid